The content is available as a PDF (153.3 KB).
Footnotes
Disclosure
Funding: none.
References
- 1.Melchionda V, Harman K. Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management. Clin Exp Dermatol. 2019;44:740–6. doi: 10.1111/ced.14041. [DOI] [PubMed] [Google Scholar]
- 2.Solimani F, Mansour Y, Didona D, Dilling A, Ghoreschi K, Meier K. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2. J Eur Acad Dermatol Venereol. 2021;35:e649–51. doi: 10.1111/jdv.17480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.De Medeiros V, Monteiro-Neto A, França D, Branco R, de Miranda Coelho E, Takano D. Pemphigus vulgaris after COVID-19: a case of induced autoimmunity. SN Compr Clin Med. 2021;3:1768–72. doi: 10.1007/s42399-021-00971-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Damiani G, Pacifico A, Pelloni F, Lorizzo M. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? J Eur Acad Dermatol Venereol. 2021;35:e645–7. doi: 10.1111/jdv.17472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tomayko M, Damsky W, Fathy R, et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol. 2021;148:750–1. doi: 10.1016/j.jaci.2021.06.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yıldırıcı Ş, Yaylı S, Demirkesen C, Vural S. New onset of pemphigus foliaceus following BNT162b2 vaccine. Dermatol Ther. 2022;35:e15381. doi: 10.1111/dth.15381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lua A, Ong F, Choo K, Yeo Y, Oh C. An unusual presentation of pemphigus foliaceus following COVID-19 vaccination. Australas J Dermatol. 2022;63:128–30. doi: 10.1111/ajd.13755. [DOI] [PubMed] [Google Scholar]
- 8.Polack F, Thomas S, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15. doi: 10.1056/NEJMoa2034577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. Nature. 2020;586:594–9. doi: 10.1038/s41586-020-2814-7. [DOI] [PubMed] [Google Scholar]
- 10.Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15:586–94. doi: 10.1038/cmi.2017.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ishay Y, Kenig A, Tsemach-Toren T, et al. Autoimmune phenomena following SARS-CoV-2 vaccination. Int Immunopharmacol. 2021;99:107970. doi: 10.1016/j.intimp.2021.107970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pardi N, Hogan M, Porter F, Weissman D. mRNA vaccines — a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261–79. doi: 10.1038/nrd.2017.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Pardi N, Hogan MJ, Naradikian MS, et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018;215:1571–88. doi: 10.1084/jem.20171450. [DOI] [PMC free article] [PubMed] [Google Scholar]